Company news
CTT Pharmaceutical Holdings, Inc. news in 2025
CTT Pharmaceutical Holdings, Inc.'s news releases, calls and decks from 2025, newest first.
CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones
December 30, 2025
CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
December 16, 2025
CTT Pharma CEO Issues Letter to Shareholders
December 2, 2025
CTT Pharma's CEO Will Issue a Letter to Shareholders
November 20, 2025
CTT Pharma's CEO will issue a Letter to Shareholders
November 20, 2025
CTT Pharma Signs Contract for $3 Million Equity Line of Credit
September 10, 2025
CTT Pharma Grant Updates
June 10, 2025
OTC Markets Group Welcomes New OTCQB Companies – March 17
March 17, 2025
CTT Pharma's CEO Issues Letter to Shareholders
March 11, 2025
CTT Pharma Uplists to the OTCQB Today
March 9, 2025
CTT Pharmaceuticals Holdings, Inc. Announces Uplisting to OTCQB Market Trading
March 4, 2025
CTT Pharma Gives Uplisting Update
March 2, 2025
CTT Pharma Gives Update On U.S. and European Patents
February 24, 2025
CTT Pharma Gives Update On NSF Grant
February 11, 2025
CTT Pharma Adds Independent Director With NIH/NSF Experience
February 4, 2025
CTT Pharma Reduces Authorized Share Count
February 2, 2025
CTT Pharma Submits Proposal for NIH Grant
January 29, 2025
Retransmission: CTT Pharma and Johns Hopkins University Submits Proposal for $15 Million NIH Grant for Smoking Cessation
January 27, 2025
CTT Pharma has engaged The OTC Markets to Uplist to The OTCQB
January 21, 2025
CTT Pharma will issue a news release January 22, 2025
January 20, 2025
CTT Pharma and Johns Hopkins University Submit Proposal for $15 Million NIH Grant For Smoking Cessation
January 6, 2025
CTT Pharma Update
January 5, 2025